In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

Unveiling the mechanism of action of a drug is key to understand the benefits and adverse reactions of a medication in an organism. However, in complex diseases such as heart diseases there is not a unique mechanism of action but a wide range of different responses depending on the patient. Exploring this collection of mechanisms is one of the clues for a future personalized medicine. The Therapeutic Performance Mapping System (TPMS) is a Systems Biology approach that generates multiple models of the mechanism of action of a drug. Each molecular mechanism generated could be associated to particular individuals, here defined as prototype-patients, hence the generation of models using TPMS technology may be used for detecting adverse effects to specific patients. TPMS operates by (1) modelling the responses in humans with an accurate description of a protein network and (2) applying a Multilayer Perceptron-like and sampling strategy to find all plausible solutions. In the present study, TPMS is applied to explore the diversity of mechanisms of action of the drug combination sacubitril/valsartan. We use TPMS to generate a wide range of models explaining the relationship between sacubitril/valsartan and heart failure (the indication), as well as evaluating their association with macular degeneration (a potential adverse effect). Among the models generated, we identify a set of mechanisms of action associated to a better response in terms of heart failure treatment, which could also be associated to macular degeneration development. Finally, a set of 30 potential biomarkers are proposed to identify mechanisms (or prototype-patients) more prone of suffering macular degeneration when presenting good heart failure response. All prototype-patients models generated are completely theoretical and therefore they do not necessarily involve clinical effects in real patients. Data and accession to software are available at http://sbi.upf.edu/data/tpms/

[1]  P. Higgins Balancing AhR-Dependent Pro-Oxidant and Nrf2-Responsive Anti-Oxidant Pathways in Age-Related Retinopathy: Is SERPINE1 Expression a Therapeutic Target in Disease Onset and Progression? , 2014, Journal of molecular and genetic medicine : an international journal of biomedical research.

[2]  Euan A Ashley,et al.  RNA-Seq identifies novel myocardial gene expression signatures of heart failure. , 2015, Genomics.

[3]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[4]  H. Soininen,et al.  Age-related macular degeneration (AMD): Alzheimer's disease in the eye? , 2011, Journal of Alzheimer's disease : JAD.

[5]  S. Grisanti,et al.  Serum cytokines as biomarkers for age-related macular degeneration , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  P. Aloy,et al.  Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems , 2016, PloS one.

[7]  O. Carretero,et al.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. , 1997, The Journal of clinical investigation.

[8]  Irwani Ibrahim,et al.  Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort , 2016, PloS one.

[9]  M. Rubio,et al.  Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarks , 2016, Scientific Reports.

[10]  O. Vuolteenaho,et al.  Evidence for a Functional Role of Angiotensin II Type 2 Receptor in the Cardiac Hypertrophic Process In Vivo in the Rat Heart , 2003, Circulation.

[11]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[12]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[13]  K. Ohno-Matsui Parallel findings in age-related macular degeneration and Alzheimer’s disease , 2011, Progress in Retinal and Eye Research.

[14]  Yi Zhang,et al.  The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis , 2016, PloS one.

[15]  F. Jaisser,et al.  Aldosterone, mineralocorticoid receptor, and heart failure , 2012, Molecular and Cellular Endocrinology.

[16]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[17]  P. Aloy,et al.  Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.

[18]  N. Turner Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling. , 2014, Vascular pharmacology.

[19]  A. Bayés‐Genís,et al.  Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach , 2017, npj Systems Biology and Applications.

[20]  Xin Jin,et al.  Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model , 2016, Scientific Reports.

[21]  S. Holland,et al.  Loss of p47phox Subunit Enhances Susceptibility to Biomechanical Stress and Heart Failure Because of Dysregulation of Cortactin and Actin Filaments , 2013, Circulation research.

[22]  J. Nowak AMD--the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics. , 2014, Acta poloniae pharmaceutica.

[23]  M. Pinazo-Durán,et al.  Retinal neurodegenerative changes in the adult insulin receptor substrate-2 deficient mouse. , 2014, Experimental eye research.

[24]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[25]  Frederick P. Roth,et al.  Next generation software for functional trend analysis , 2009, Bioinform..

[26]  B. Sobel,et al.  A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart , 2009, Experimental biology and medicine.

[27]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[28]  C. Tei,et al.  Effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[29]  Anna Strömberg,et al.  ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008 (ENDING) , 2009 .

[30]  J. Mas,et al.  Systems biology applied to non-alcoholic fatty liver disease (NAFLD): treatment selection based on the mechanism of action of nutraceuticals , 2014 .

[31]  R. Sullivan,et al.  Dendritic and synaptic plasticity of neurons in the human age-related macular degeneration retina. , 2007, Investigative ophthalmology & visual science.

[32]  S. DeKosky,et al.  Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations. , 2016, JAMA.

[33]  M. Mamas,et al.  Role of advanced glycation end products in cardiovascular disease. , 2012, World journal of cardiology.

[34]  J. Vader,et al.  Potential Expanded Indications for Neprilysin Inhibitors , 2017, Current Heart Failure Reports.

[35]  Hyojin Kim,et al.  TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions , 2017, Nucleic Acids Res..

[36]  W. Hsueh,et al.  Angiotensin II Enhances Integrin and α-Actinin Expression in Adult Rat Cardiac Fibroblasts , 2000 .

[37]  J. Glenn,et al.  The role of advanced glycation end products in retinal ageing and disease. , 2009, Biochimica et biophysica acta.

[38]  V. Deltuva,et al.  The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[39]  P. Mitchell,et al.  Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis , 2010, BMC ophthalmology.

[40]  R. Mullins,et al.  Angiogenin in age-related macular degeneration , 2011, Molecular vision.

[41]  Lei Xi,et al.  Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges , 2018, Journal of geriatric cardiology : JGC.

[42]  Stefano Mancuso,et al.  Aromatic and proteomic analyses corroborate the distinction between Mediterranean landraces and modern varieties of durum wheat , 2016, Scientific Reports.

[43]  D. Sawyer,et al.  Neuregulin as a Heart Failure Therapy and Mediator of Reverse Remodeling , 2014, Current Heart Failure Reports.

[44]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[45]  Philip E. Bourne,et al.  SuperTarget goes quantitative: update on drug–target interactions , 2011, Nucleic Acids Res..

[46]  S. Heymans,et al.  Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes , 2019, JACC. Basic to translational science.

[47]  D. Pak,et al.  Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking. , 2013, Biochemical and biophysical research communications.

[48]  Gordon Clapworthy,et al.  The virtual physiological human: challenges and opportunities , 2006, 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro, 2006..

[49]  E. Cabré,et al.  ANP32E, a Protein Involved in Steroid-Refractoriness in Ulcerative Colitis, Identified by a Systems Biology Approach , 2018, Journal of Crohn's & colitis.

[50]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[51]  Junfa Li,et al.  TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration , 2017, Scientific Reports.

[52]  N. Frangogiannis,et al.  The role of IL-1 in the pathogenesis of heart disease , 2009, Archivum Immunologiae et Therapiae Experimentalis.

[53]  R. Frank Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. , 1997, Ophthalmic research.

[54]  A. Salminen,et al.  Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration , 2013, Autophagy.

[55]  Laura L. Elo,et al.  A systematic evaluation of normalization methods in quantitative label-free proteomics , 2016, Briefings Bioinform..

[56]  T. Matsui,et al.  Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. , 2011, Current pharmaceutical design.

[57]  X. Navarro,et al.  Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence , 2018, Scientific Reports.

[58]  M. Brantley,et al.  The effect of genetic variants in SERPING1 on the risk of neovascular age-related macular degeneration , 2010, British Journal of Ophthalmology.

[59]  H. Cingolani,et al.  The Autocrine/Paracrine Loop After Myocardial Stretch: Mineralocorticoid Receptor Activation , 2013, Current cardiology reviews.

[60]  Merlin C. Thomas,et al.  Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis , 2018, The Journal of clinical investigation.

[61]  Marco Viceconti,et al.  In silico clinical trials: how computer simulation will transform the biomedical industry , 2016 .

[62]  Yanick P Hagemeijer,et al.  Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure , 2017, Scientific Reports.

[63]  L. Ruilope,et al.  Valsartan improves fibrinolytic balance in atherosclerotic rabbits , 2002, Journal of hypertension.

[64]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[65]  N. Greig,et al.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. , 2015, Current Alzheimer research.

[66]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[67]  Rachel C. Childers,et al.  Role of the cytoskeleton in the development of a hypofibrotic cardiac fibroblast phenotype in volume overload heart failure. , 2019, American journal of physiology. Heart and circulatory physiology.

[68]  N. V. Karsanov,et al.  Thin myofilament proteins in norm and heart failure I. Polymerizability of myocardial Straub actin in acute and chronic heart failure , 1986, Basic Research in Cardiology.

[69]  J. Hollyfield,et al.  Quantitative Proteomics: Comparison of the Macular Bruch Membrane/Choroid Complex from Age-related Macular Degeneration and Normal Eyes , 2010, Molecular & Cellular Proteomics.

[70]  R. Spaide Choroidal Neovascularization , 2020, Pathologic Myopia.

[71]  L. Leiter Therapy of heart failure. , 1961, Chicago medicine.

[72]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[73]  Rafael C. Jimenez,et al.  The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..

[74]  Anil K. Jain,et al.  A modified Hausdorff distance for object matching , 1994, Proceedings of 12th International Conference on Pattern Recognition.

[75]  C. Lang,et al.  Sacubitril/valsartan: beyond natriuretic peptides , 2017, Heart.

[76]  Damian Szklarczyk,et al.  STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data , 2015, Nucleic Acids Res..

[77]  Marco Viceconti,et al.  In silico clinical trials: concepts and early adoptions , 2019, Briefings Bioinform..

[78]  F. Rutten,et al.  Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review , 2016, European journal of heart failure.

[79]  Akshay S. Desai,et al.  MINI-FOCUS ISSUE: HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) , 2022 .

[80]  Kazuharu Furutani,et al.  HD Physiology Project—Japanese efforts to promote multilevel integrative systems biology and physiome research , 2016, npj Systems Biology and Applications.

[81]  Elisa Garbayo,et al.  Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion , 2016, Scientific Reports.

[82]  Natalie Wilson Human Protein Reference Database , 2004, Nature Reviews Genetics.

[83]  E. Guney,et al.  GUILDify v2.0: A Tool to Identify Molecular Networks Underlying Human Diseases, Their Comorbidities and Their Druggable Targets. , 2019, Journal of molecular biology.

[84]  Jean-Philippe Rennard,et al.  Stochastic Optimization Algorithms , 2007, ArXiv.